Get the Stockscreener App
74.37
3.26%
2.35
After Hours:
74.37
Henry Schein Inc stock is traded at $74.37, with a volume of 2.45M.
It is up +3.26% in the last 24 hours and up +0.58% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
See More
Previous Close:
$72.02
Open:
$71.5
24h Volume:
2.45M
Relative Volume:
1.83
Market Cap:
$8.53B
Revenue:
$13.18B
Net Income/Loss:
$419.00M
P/E Ratio:
22.74
EPS:
3.2704
Net Cash Flow:
$521.00M
1W Performance:
-2.30%
1M Performance:
+0.58%
6M Performance:
+3.28%
1Y Performance:
+11.70%
1-Day Range:
$70.06
$74.77
1-Week Range:
$70.06
$76.11
52-Week Range:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
74.37 | 8.26B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
801.01 | 98.95B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
305.90 | 59.07B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
197.00 | 46.15B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
2.20 | 1.83B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-26 | Initiated | BTIG Research | Neutral |
| Apr-15-26 | Initiated | Citigroup | Buy |
| Feb-23-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein Q1 Earnings Call Highlights - Yahoo Finance
Piper Sandler Cuts Price Target on Henry Schein to $91 From $99 - marketscreener.com
Jefferies Adjusts Price Target on Henry Schein to $80 From $89, Maintains Hold Rating - marketscreener.com
Henry Schein (Nasdaq: HSIC) reports Q1 2026 net sales of $3,368M - Stock Titan
Henry Schein, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Henry Schein (HSIC) Q1 2026 Earnings Transcript - AOL.com
Henry Schein tops expectations, but shares dip slightly after results - Yahoo Finance
Earnings call transcript: Henry Schein Q1 2026 beats expectations, stock dips - Investing.com
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics - Yahoo Finance UK
HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises - TradingView
Henry Schein, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HSIC) 2026-05-05 - Seeking Alpha
Transcript: Henry Schein Q1 2026 Earnings Conference Call - Benzinga
Henry Schein, Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026 - marketscreener.com
Henry Schein : Q1 2026 Earnings Conference Call - marketscreener.com
Henry Schein Inc (NASDAQ:HSIC) Surges After Q1 Earnings Beat - ChartMill
Henry Schein beats estimates but stock edges down By Investing.com - Investing.com Nigeria
Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Henry Schein beats estimates but stock edges down - Investing.com
Henry Schein Fiscal Q1 Non-GAAP Earnings, Net Sales Rise; Reaffirms 2026 Outlook - marketscreener.com
Earnings Flash (HSIC) Henry Schein, Inc. Reports Q1 Revenue $3.37B, vs. FactSet Est of $3.34B - marketscreener.com
Earnings Flash (HSIC) Henry Schein, Inc. Posts Q1 Adjusted EPS $1.32 per Share, vs. FactSet Est of $1.22 - marketscreener.com
(HSIC) Henry Schein Expects Fiscal 2026 Non-GAAP EPS Range $5.23 to $5.37, vs. FactSet Est of $5.32 - marketscreener.com
Henry Schein (NASDAQ:HSIC) Beats Q1 CY2026 Sales Expectations - TradingView
Henry Schein (NASDAQ: HSIC) Q1 2026 sales up 6.3% as EPS jumps - Stock Titan
Henry Schein Q1 adjusted profit beats estimates - TradingView
Henry Schein: Q1 Earnings Snapshot - KVUE
Henry Schein backs $200M income-improvement plan after Q1 - Stock Titan
Henry Schein Orthodontics adds Froggymouth to portfolio - DrBicuspid.com
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein Q1 2026 earnings preview - MSN
All eyes on Henry Schein earnings as dental growth questions loom - Investing.com Nigeria
Henry Schein (HSIC) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Henry Schein to Participate in Upcoming Investor Conferences in May - The Joplin Globe
Two Henry Schein investor presentations this month will stream live - Stock Titan
Henry Schein, Inc. $HSIC Shares Sold by Vanguard Group Inc. - MarketBeat
Melville Employees Assemble 1,500 Hygiene Kits For Families Of Sick Children - Patch
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of "Hold" from Analysts - MarketBeat
quip Announces Supplier Package Agreement with Henry Schein for Availability of the Ultra Next-Generation Smart Sonic Toothbrush to Dental Professionals Nationwide - Dentistry Today
On Our Island: Long Island nonprofits and businesses support mental health and cancer research - Long Island Business News
Vanguard Capital Management (HSIC) reports 6.36% ownership in Henry Schein - Stock Titan
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
Henry Schein Stock (US42548G1040): Set to Report Q1 2026 Results Today - AD HOC NEWS
Henry Schein (HSIC) down 9.4% since last earnings report: Can it rebound? - MSN
Earnings Preview: Henry Schein to Report Financial Results Pre-market on May 05 - Moomoo
Henry Schein Inc (HSIC) Stock Down 3.0% -- Now Undervalued? GF S - GuruFocus
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Greenlight Capital Adds Henry Schein Shares Amid Leadership Transition - HarianBasis.co
Henry Schein Inc. (HSIC): David Einhorn Is Buying This Health Stock - Yahoo Finance
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Henry Schein One Launches MCP Layer - Dentistry Today
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.80%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):